로딩 중…
지수 로딩 중…
Annexon, Inc.
ANNX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$5.25+2.94%
2026-08-03
Financials
Valuation Metrics
Annexon, Inc.'s Market Cap is $860M. At end of 2025 it was $749M. Ranked #2580 of 3,111 in US market (top 83%), #1078 of 1,445 on NASDAQ (top 75%), #201 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 75%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $860M | US#2,580/3,111 Sec#201/269 |
| Revenue | $0.00 | US#2,980/3,111 Sec#205/269 |
| Net Income | $-196M | US—/3,111 Sec—/269 |
| Total Assets | $263M | US#2,945/3,111 Sec#233/269 |
| Net Assets | $205M | US#2,738/3,111 Sec#199/269 |
| Value | ||
| P/B | 4.21x | US#2,012/3,111 Sec#122/269 |
| FCF Yield | -21.29% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROE | -96.06% | US#2,852/3,111 Sec#219/269 |
| ROA | -74.74% | US#3,036/3,111 Sec#254/269 |
| Financial Health | ||
| Debt Ratio | 28.53% | US#312/3,111 Sec#105/269 |
| Total Debt | $25M | US#2,689/3,111 Sec#173/269 |
| FCF | $-183M | US#2,725/3,111 Sec#210/269 |
| Cash | $175M | US#1,820/3,111 Sec#128/269 |
| Current Ratio | 6.35x | US#372/3,111 Sec#123/269 |
| Performance | ||
| 1Y Return | 114.29% | US#247/3,111 Sec#76/269 |
| 1M Return | -3.85% | US#2,375/3,111 Sec#168/269 |
| From 52W High | -26.88% | US#2,067/3,111 Sec#154/269 |
| 1Y MDD | -35.06% | US#1,691/3,111 Sec#112/269 |
| Trading | ||
| Volume | 2,657,681 shares | US#653/3,111 Sec#51/269 |
| Trading Value | $14M | US#2,127/3,111 Sec#165/269 |
| Per Share | ||
| EPS | $-1.06 | US—/3,111 Sec—/269 |
| BPS | $1.08 | US#2,619/3,111 Sec#201/269 |